{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-065188","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.835053+00:00","generated_at":"2026-05-31T13:13:09.098120+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Elevai Labs CMO and board member Hatem Abou-Sayed resigns effective immediately","bullets":["Dr. Hatem Abou-Sayed resigned as Chief Medical Officer and board member on August 1, 2024.","Resignation not due to any disagreement with company operations, policies, or practices.","No replacement named; CEO Graydon Bensler also serves as CFO and director."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-065188","json":"https://secwatch.observer/filing/0001213900-24-065188.json","markdown":"https://secwatch.observer/filing/0001213900-24-065188.md","text":"https://secwatch.observer/filing/0001213900-24-065188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024065188/0001213900-24-065188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024065188/ea021054901-8k_elevai.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:13:09.098120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"713dd5d7b9","claim":"Hatem Abou-Sayed resigned as Chief Medical Officer at PMGC Holdings Inc..","evidence_excerpt":"On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024065188/0001213900-24-065188-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"94d06b1eee","claim":"Hatem Abou-Sayed resigned as member of the Board of Directors at PMGC Holdings Inc..","evidence_excerpt":"On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024065188/0001213900-24-065188-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}